Post-liver transplantation lymphoproliferative disorders with and without infusions of donor bone marrow cells

Critical Reviews in Oncogenesis

Volumn 10, Issue 3, 1999, Pages 239-245

  Restrepo, Alvaro ^a   Albrecht, Federico ^a   Raez, Luis E ^a   Fernandez, Hugo F ^a   Nassiri, Mehdi ^a   Byrne Jr , Gerald ^a   Cassileth, Peter A ^a  

^a NONE

Author keywords

Bone marrow transplant (BMT); Epstein Barr virus (EBV); Liver transplantation; Non Hodgkin's lymphoma (NHL); Postliver transplantation lymphoproliferative disorder (PLTD)

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MONOCLONAL ANTIBODY; OKT 3; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; SURVIVAL;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; LYMPHOMA, NON-HODGKIN; MALE;

EID: 0032838501     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Appalls, G. and R. Henderson: Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipients. Lancet, 342:1514-1516 (1993).
2. Armitage, J. M., R. Kormos, and R. S. Stuart: Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J. Heart Lung Transplant, 10:877-886 (1991).
3. Armitage, J. M., F. Fricker, and P. del Nido: A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J. Thorac. Cardiovasc. Surg., 105:464-472 (1993).
4. Barber, W. H., J. Mankin, D. Laskow, M. Deierhoi, B. Julian, J. Curtis, and A. Diethelm. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation, 51:70-75 (1991).
5. Beveridge, T., P. Rupp, and C. McKibbin: Lymphomas and lymphoproliferative lesions developing under cyclosponn therapy (Letter). Lancet, 1:788 (1984).
6. Cohen, K. I.: Epstein-Bar virus lynmphoproliferative disease associated with acquired immunodeficiency. Proc. Natl. Acad. Sci. U.S.A., 86:9558-9561 (1991).
7. Fischer, A., S. Blanche, and K. Bidors: Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N. Engl. J. Med., 324:1451-1456 (1991).
8. Fontes, P., A. Rao, A. Demetris, A. Zeevi, M. Trucco, P. Carroll, W. Rybka, C. Ricodri, F. Dodson, R. Shapiro, A. Tzakis, S. Todo, K. Abu-Elmagd, M. Jordan, J. Fung, and T. Starzl. Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation. Lancet, 344:151-155 (1994).
9. Frizzea, G.: Immunosuppression, autoimmunity and lymphoproliferative disorders. Hum. Pathol., 25:627-629 (1994).
10. Hanto, D. W., G. Frizzera, K. Gajl-Peczalska, H. Balfour, R. Simmons, and J. Naranan: Acyclovir therapy of Epstein-Barr-induced post transplant lymphoproliferative diseases. Transplant. Proc., 17:89-92 (1985).
11. Joske, D. and H. Knecht: Epstein-Barr virus in lymphomas: a review. Blood Rev., 7:215-222 (1993).
12. Klein, G.: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, 77:791-793 (1994).
13. Levy, M., L. Backna, B. Husberg, R. Goldstein, R. McMillan, G. Kimalm: De novo malignancy following liver transplantation single-center study. Transplant. Proc., 25:1397-1399 (1993).
14. List, A. F., A. Greco, and L. Vogler: Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J. Clin. Oncol., 5:1673-1689 (1987).
15. Monaco, A. P., A. Clark, M. Wood, A. Sahyoun, S. Codish, and R. Brown: Possible active enhancement of a human cadaver renal allograft with antilymphocytic serum (ALS) and done bone marrow: case report of an initial attempt. Surgery, 79:384-392 (1976).
16. Monaco, A. P., M. Wood, and P. Russel: Studies on heterologous anti-lymphocyte serum in mice. III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum. Ann. New York̀ Acad. Sci., 129:190-206 (1966).
17. Morgan, G. and R. Seperina: Lymphoproliferative disease after pediatric liver transplantation. J. Pediatric Surg., 29(9):1192-1196. (1994).
18. Opelz, G. and R. Henderson: Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipients (see comments). Lancet, 342:1514-1516 (1993).
19. Palesnik, M. A., L. Makowka, and T. Starzl: The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr. Probl. Surg., 25:367-472 (1988).
20. Papadopoulos, E. B., M. Ladanyi, and D. Emanuel: Infusions of donor leukocytes to treat Epstein-Barr-virus-associated lymphoproliferative disorders after allogenic bone marrow transplantation. N. Engl. J. Med., 330:1185-1191 (1994).
21. Regard, T., W. Andrew, and M. Foster: Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipient. Transplant. Proc., 23:1473-1476 (1991).
22. Ricordi, C, A. Tzakis, A. Demetris, S. Ildstad, A. Zeevi, W. Rybka, M. Nalesnik, F. Ukah, P. Fontes, E. Ball, and T. Starzl: Reversal of graft-vs.-host disease with infusion of stored autologous bone marrow cells following combined liver-bone marrow allotransplantation in man. Transplantation Sci., 3:76-77 (1993).
23. Rooney, C. M, C. Smith, and C. Young: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus lymphoproliferation. Lancet, 345:9-13 (1994).
24. Shapiro, R. S, A. Chauvenet, and McGuire: Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravneous gamma globulin. N. Engl. J. Med., 318:1334 (1988).
25. Shapiro, R. S, K. McClain, and G. Frizzera: Epstein-Barr virus associated B cell lymphoprolfierative disorders following bone marrow transplantation. Blood, 71:1234-1243 (1988).
26. Starzl, T. E., A. Demetris, M. Noriko, T. Ildstad, C. Ricordi, and M. Trucco: Cell migration, chimerism, and graft acceptance. Lancet, 339:1579-1582 (1992).
27. Starzl, T. E., A. Demtris, M. Trucco, I. Ramos, A. Zeevi, W. Rudert, M. Kocoua, C. Ricordi, S. Ildstad, and N. Murase. Systemic chimerism in human female recipients of male livers. Lancet, 340:876-877 (1992).
28. Starzl, T. E., A. Demetris, M. Trucco, A. Zeevi, H. Ramos, P. Terasaki, W. Rudxert, M. Kocova, C. Rechart, A. Ildstad, and N. Murase: Chimerism and donor specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation, 55:1272-1277 (1993).
29. Starzl, T. E., A. Demtris, M. Trucco, N. Murase, C. Rechart, S. Ildstad: Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hematology, 17:1127-1152 (1993).
30. Starzl, T. E., M. Nalesnik, and K. Porterl: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, 1:583-587 (1984).
31. Stieber A. C., O. Boillot, F. Scotti, M. Nalesnik, R. Gordon, and T. Starzl: The surgical implications of the post transplant lymphoproliferative disorders. Trans. Plant Proc., 23:1477-1479 (1991).
32. Strauss, S. E., J. Cohen, G. Tosato, and J. Meier: Epstein-Barr virus infections, biology pathogenesis and management. Ann. Intern. Med., 118:45-58 (1992).
33. Swinnen, L. J., M. Costanzo-Nordin, and S. Fisher: Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclinal antibody OKT3 in cardiac transplant recipients. N. Engl. J. Med., 323:1723-1728 (1990).
34. Swinnen, L. J., G. Mullen, and T. Carr: Aggressive treatment for post cardiac transplant lymphoproliferation. Blood, 86:3333-3340, (1995).
35. Walker, R. C., W. Marshall, and J. Strickler: Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin. Infect Dis., 20:1346-1353 (1995).
36. Witherspoon R. P., L. Fisher, and G. Schochl: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia (see comments). N. Engl. J. Med., 321:784-789 (1989).
37. Zutter M. M., P. Martin, and G. Sale: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood, 75:520-529 (1988).